This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vernace, M. A. Articles by Wilkes, B. M. Search for Related Content PubMed PubMed Citation Articles by Vernace, M. A. Articles by Wilkes, B. M.

Hypertension, Vol 23, 853-856, Copyright © 1994 by American Heart Association

ARTICLES

Effects of angiotensin receptor subtype inhibitors on plasma angiotensin clearance

MA Vernace, PF Mento, ME Maita and BM Wilkes
Division of Nephrology and Hypertension, North Shore University Hospital, Manhasset, NY 11030.

The aim of this study was to determine whether angiotensin receptor subtypes play a role in angiotensin clearance from plasma. Angiotensin metabolic clearance rate was measured in rats by the constant infusion method. Increasing doses of angiotensin II were infused for 15 minutes, and blood was sampled for angiotensin II. The type 1 angiotensin II receptor antagonist losartan decreased the apparent metabolic clearance rate by > 50% at low-dose infusion, suggesting that type 1 angiotensin II receptors are involved in angiotensin II clearance from plasma. At higher angiotensin infusion rates, the-metabolic clearance rate of angiotensin was unaffected. To dissect the contribution of renin- generated angiotensin, additional experiments were performed in nephrectomized rats. In anephric rats, angiotensin clearance was unaffected by type 1 angiotensin II receptor inhibition. In contrast, the type 2 angiotensin II receptor ligand PD123319 in intact rats caused a > 50% increase in metabolic clearance rate of angiotensin at higher infusion rates (P < .05). In anephric rats, the type 2 angiotensin II receptor ligand alone or combined with type 1 receptor inhibition was without effect on the metabolic clearance rate or the T1/2 for angiotensin disappearance. These data argue against a role for type 1 or 2 angiotensin II receptors as clearance receptors. Increased clearance of angiotensin by type 2 receptor blockade in the presence but not the absence of kidneys suggests an alternative renal mechanism by which selective type 2 ligands may alter angiotensin effects.

This article has been cited by other articles:

				C. Wamberg, R. R. Plovsing, N. C. F. Sandgaard, and P. Bie Effects of different angiotensins during acute, double blockade of the renin system in conscious dogs Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2003; 285(5): R971 - R980. [Abstract] [Full Text] [PDF]

				R. Wang, C. Ramos, I. Joshi, A. Zagariya, A. Pardo, M. Selman, and B. D. Uhal Human lung myofibroblast-derived inducers of alveolar epithelial apoptosis identified as angiotensin peptides Am J Physiol Lung Cell Mol Physiol, December 1, 1999; 277(6): L1158 - L1164. [Abstract] [Full Text] [PDF]

				R. Wang, A. Zagariya, O. Ibarra-Sunga, C. Gidea, E. Ang, S. Deshmukh, G. Chaudhary, J. Baraboutis, G. Filippatos, and B. D. Uhal Angiotensin II induces apoptosis in human and rat alveolar epithelial cells Am J Physiol Lung Cell Mol Physiol, May 1, 1999; 276(5): L885 - L889. [Abstract] [Full Text] [PDF]

				K. Yamada, S. N. Iyer, M. C. Chappell, D. Ganten, and C. M. Ferrario Converting Enzyme Determines Plasma Clearance of Angiotensin-(1–7) Hypertension, September 1, 1998; 32(3): 496 - 502. [Abstract] [Full Text] [PDF]

				K. F. Hilgers, E. Bingener, C. Stumpf, D. N. Muller, R. E. Schmieder, and R. Veelken Angiotensinases Restrict Locally Generated Angiotensin II to the Blood Vessel Wall Hypertension, January 1, 1998; 31(1): 368 - 372. [Abstract] [Full Text] [PDF]

				L. Hein, L. Meinel, R. E. Pratt, V. J. Dzau, and B. K. Kobilka Intracellular Trafficking of Angiotensin II and its AT1 and AT2 Receptors: Evidence for Selective Sorting of Receptor and Ligand Mol. Endocrinol., August 1, 1997; 11(9): 1266 - 1277. [Abstract] [Full Text]